Jiao, Y., Watts, T., Xue, J., Hannafon, B., & Ding, W. (2018). Sorafenib and docosahexaenoic acid act in synergy to suppress cancer cell viability: A role of heme oxygenase 1. BMC Cancer.
Styl cytowania ChicagoJiao, Yang, Tanya Watts, Jing Xue, Bethany Hannafon, i Wei-Qun Ding. "Sorafenib and Docosahexaenoic Acid Act in Synergy to Suppress Cancer Cell Viability: A Role of Heme Oxygenase 1." BMC Cancer 2018.
Styl cytowania MLAJiao, Yang, et al. "Sorafenib and Docosahexaenoic Acid Act in Synergy to Suppress Cancer Cell Viability: A Role of Heme Oxygenase 1." BMC Cancer 2018.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..